High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)
Clinical trial NCT03217903 · UNKNOWN
Trial details
- NCT number
- NCT03217903
- Sponsor
- Central Hospital, Nancy, France
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-12
- Primary completion
- 2022-01-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.